Results 191 to 200 of about 121,627 (255)
Vasopressin: physiology, assessment and osmosensation
Journal of Internal Medicine, 2017 Lise Bankir +3 more
exaly +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Effect of exogenous vasopressin on vasopressin release
American Journal of Physiology-Endocrinology and Metabolism, 1984To characterize the influence of extracellular volume status on vasopressin pharmacokinetics, eleven young (aged 19-31 yr) and four old (aged 62-80 yr) subjects received bolus injections of 1 mU/kg Pitressin or synthetic arginine vasopressin following 6 days of sodium depletion (10 meq Na/day) or sodium loading (250 meq Na/day).
G. L. Robertson +3 more
openaire +3 more sources
Mice Genetically Deficient in Vasopressin V1a and V1b Receptors Are Resistant to Jet Lag
Science, 2013Yoshiaki Yamaguchi +2 more
exaly +2 more sources
Oxytocin, vasopressin, and human social behavior
Frontiers in Neuroendocrinology, 2009 Bernadette von Dawans, Gregor Domes
exaly +2 more sources
Vasopressin and vasopressin receptors in brain edema
2020Vasopressin is a peptide hormone produced in the hypothalamus and released from the posterior pituitary. Secretion of vasopressin is followed by activation of its receptors V1a, V1b, and V2 throughout the body. Each receptor type is responsible for a specific function of vasopressin.
J Paul Elliott +2 more
openaire +2 more sources
Journal of Cardiovascular Pharmacology, 1986
The nonapeptide vasopressin is synthetized as part of a longer common precursor polypeptide, together with its carrier protein neurophysin and a glycopeptide of unknown function. The gene for this common precursor has been isolated and sequenced and shown to comprise three exons encoding, respectively, the protein domains approximately corresponding to
Dietmar Richter +2 more
openaire +3 more sources
The nonapeptide vasopressin is synthetized as part of a longer common precursor polypeptide, together with its carrier protein neurophysin and a glycopeptide of unknown function. The gene for this common precursor has been isolated and sequenced and shown to comprise three exons encoding, respectively, the protein domains approximately corresponding to
Dietmar Richter +2 more
openaire +3 more sources
Vasopressin and Vasopressin Antagonists in Heart Failure
2017Despite the introduction of multiple new pharmacological agents over the past three decades in the field of heart failure (HF), overall prognosis remains poor. Hyponatremia is prevalent in HF patients and has been suggested as a contributor to poor response to standard therapy.
Finn Gustafsson +1 more
openaire +3 more sources
Cellular and Molecular Life Sciences, 2006
Effects of vasopressin via V1a- and V2-receptors are closely implicated in a variety of water-retaining diseases and cardiovascular diseases, including heart failure, hyponatraemia, hypertension, renal diseases, syndrome of inappropriate antidiuretic hormone secretion, cirrhosis and ocular hypertension.
Lemmens, Rosa, Kamyar, Majid-Reza
openaire +2 more sources
Effects of vasopressin via V1a- and V2-receptors are closely implicated in a variety of water-retaining diseases and cardiovascular diseases, including heart failure, hyponatraemia, hypertension, renal diseases, syndrome of inappropriate antidiuretic hormone secretion, cirrhosis and ocular hypertension.
Lemmens, Rosa, Kamyar, Majid-Reza
openaire +2 more sources
Current Opinion in Critical Care, 2004
Vasopressin is one of the most important endogenously released stress hormones during shock. In this review, studies published in the past year that add to our understanding of the use of vasopressin in the ICU are discussed.Endogenous vasopressin levels are inappropriately low in adults with severe sepsis but not in children with meningococcal septic ...
Keith R. Walley, Cheryl L. Holmes
openaire +3 more sources
Vasopressin is one of the most important endogenously released stress hormones during shock. In this review, studies published in the past year that add to our understanding of the use of vasopressin in the ICU are discussed.Endogenous vasopressin levels are inappropriately low in adults with severe sepsis but not in children with meningococcal septic ...
Keith R. Walley, Cheryl L. Holmes
openaire +3 more sources
Trends in Endocrinology & Metabolism, 2000
The biological effects of arginine vasopressin (AVP) are mediated by three receptor subtypes: the V1a and V1b receptors that activate phospholipases via Gq/11, and the V2 receptor that activates adenylyl cyclase by interacting with Gs. Isolation of the cDNAs encoding the V1a and V1b receptor subtypes explained the tissue variability of V1 antagonist ...
openaire +3 more sources
The biological effects of arginine vasopressin (AVP) are mediated by three receptor subtypes: the V1a and V1b receptors that activate phospholipases via Gq/11, and the V2 receptor that activates adenylyl cyclase by interacting with Gs. Isolation of the cDNAs encoding the V1a and V1b receptor subtypes explained the tissue variability of V1 antagonist ...
openaire +3 more sources